CT 32228

Overview

CT 32228 is an inhibitor of lysophosphatidic acid acyltransferase-β ( LPAAT-β ). CT 32228 inhibits tumor cell growth. CT 32228 exhibits IC 50 values of around 0.1-0.8 μM in various leukemia cell lines. CT 32228 induces caspase activation in DHL-4 and Ramos cells. CT 32228 induces apoptosis when combined with Rituximab ( HY-P9913 ). CT 32228 results in a 50% xenograft growth delay in vivo. CT 32228 can be studied in research on acute leukemia.

Application

Products | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-178712
• CAS No.: 521064-34-6
• Molecular Formula: C16H13BrClN5
• Molecular Weight: 390.66
• Purity: 95.27%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source